AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding AbCellera Biologics Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 203 | 2 | 183 | −18 |
| Shares | 127.9M | 23.3K | 130.1M | +2.15M (+1.7%) |
| Value | $1.30B | $236.6K | $980.7M | −$315.8M (−24.4%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 556,274 | $4.19M | 0.05% |
| Duality Advisers, LP | 126,388 | $953.0K | 0.11% |
| Voloridge Investment Management, LLC | 125,244 | $944.3K | 0.00% |
| ETF Managers Group, LLC | 94,496 | $712.5K | 0.02% |
| Jump Financial, LLC | 92,000 | $693.7K | 0.03% |
| Denali Advisors LLC | 87,600 | $660.5K | 0.27% |
| PDT Partners, LLC | 84,464 | $636.9K | 0.09% |
| Capula Management Ltd | 59,560 | $449.1K | 0.04% |
| SG Americas Securities, LLC | 36,208 | $273.0K | 0.00% |
| Ergoteles LLC | 35,048 | $264.3K | 0.01% |
| Kula Investments, LLC | 34,489 | $260.0K | 0.06% |
| Verition Fund Management LLC | 26,088 | $196.7K | 0.00% |
| Prime Capital Investment Advisors, LLC | 19,432 | $146.5K | 0.01% |
| Nomura Holdings Inc | 15,400 | $116.1K | 0.00% |
| Westwood Holdings Group Inc. | 15,408 | $116.0K | 0.00% |
| Walleye Trading LLC | 11,629 | $87.7K | 0.00% |
| Two Sigma Securities, LLC | 11,212 | $84.5K | 0.01% |
| Janney Montgomery Scott LLC | 10,193 | $77.0K | 0.00% |
| Gladius Capital Management LP | 3,361 | $25.3K | 0.01% |
| Slow Capital, Inc. | 1,638 | $12.4K | 0.00% |
| Fisher Asset Management, LLC | 273 | $2.06K | 0.00% |
| Lindbrook Capital, LLC | 33 | $249 | 0.00% |
Sold out (40)
Institutions that held AbCellera Biologics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (2)
Institutions that held AbCellera Biologics Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Neo Ivy Capital Management | 23,178 | $235.0K |
| Trustcore Financial Services, LLC | 161 | $1.63K |